Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Genuth

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Family Practice|December 3, 1998
For aggressive preventive management of type 2 diabetes. What is the evidence and is it enough?S Genuth
Endocrinology and Metabolism Clinics of North America|June 1, 1992
Management of the adult onset diabetic with sulfonylurea drug failureS Genuth
Obesity Research|April 11, 2000
Implications of the United Kingdom prospective diabetes study for patients with obesity and type 2 diabetesS Genuth
Annals of Internal Medicine|January 1, 1996
Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitusS Genuth
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1996
Summary and perspectives on impaired glucose toleranceS Genuth
Diabetic Medicine : a Journal of the British Diabetic Association|September 9, 2008
The UKPDS and its global impactS Genuth
The Journal of Family Practice|December 3, 1998
United Kingdom prospective diabetes study results are inS Genuth
Diabetes Care|September 1, 1981
Is NIDDM just a receptor disease?S Genuth
Diabetes Care|December 1, 1990
Insulin use in NIDDMS Genuth
The New England Journal of Medicine|July 12, 1973
Insulin response to intravenous alimentationS Genuth
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Family Practice|December 3, 1998
For aggressive preventive management of type 2 diabetes. What is the evidence and is it enough?S Genuth
Endocrinology and Metabolism Clinics of North America|June 1, 1992
Management of the adult onset diabetic with sulfonylurea drug failureS Genuth
Obesity Research|April 11, 2000
Implications of the United Kingdom prospective diabetes study for patients with obesity and type 2 diabetesS Genuth
Annals of Internal Medicine|January 1, 1996
Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitusS Genuth
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1996
Summary and perspectives on impaired glucose toleranceS Genuth
Diabetic Medicine : a Journal of the British Diabetic Association|September 9, 2008
The UKPDS and its global impactS Genuth
The Journal of Family Practice|December 3, 1998
United Kingdom prospective diabetes study results are inS Genuth
Diabetes Care|September 1, 1981
Is NIDDM just a receptor disease?S Genuth
Diabetes Care|December 1, 1990
Insulin use in NIDDMS Genuth
The New England Journal of Medicine|July 12, 1973
Insulin response to intravenous alimentationS Genuth
Pageof 3